See more : Shilp Gravures Limited (SHILGRAVQ.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Jushi Holdings Inc. (JUSHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jushi Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- AVIC Shenyang Aircraft Company Limited (600760.SS) Income Statement Analysis – Financial Results
- Tiga Acquisition Corp. (TINV-UN) Income Statement Analysis – Financial Results
- Satu Holdings Limited (8392.HK) Income Statement Analysis – Financial Results
- Zhejiang Sunrise Garment Group Co., Ltd. (605138.SS) Income Statement Analysis – Financial Results
- SIMMTECH Co., Ltd. (222800.KQ) Income Statement Analysis – Financial Results
Jushi Holdings Inc. (JUSHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jushico.com
About Jushi Holdings Inc.
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabidiol supplements, tinctures, capsules, softgels, and topicals under The Bank, The Lab, Nira+ Medicinals, Seche, Tasteology, and Nira brands. As of June 6, 2022, it operated 33 BEYOND/HELLO retail locations. The company was incorporated in 2007 and is headquartered in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 269.45M | 284.28M | 209.29M | 80.77M | 10.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 153.22M | 188.81M | 121.92M | 37.70M | 5.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 116.23M | 95.48M | 87.37M | 43.07M | 4.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 43.14% | 33.59% | 41.75% | 53.32% | 47.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 315.63K | 914.63K | 1.23M | 1.42M | 3.04M | 1.75M | 26.77K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.96K | 0.00 | 113.04K | 194.52K | 165.85K | 228.23K | 0.00 | 0.00 |
| SG&A | 110.47M | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 336.59K | 914.63K | 1.23M | 1.42M | 3.21M | 1.98M | 26.77K | 37.12K |
| Other Expenses | 8.57M | -482.00K | 6.84M | 5.07M | 2.16M | 0.00 | 0.00 | 1.17K | 37.70K | 279.10K | 134.92K | 155.94K | 30.32K | 0.00 | 0.00 |
| Operating Expenses | 119.05M | 156.17M | 108.53M | 51.49M | 35.50M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
| Cost & Expenses | 272.26M | 344.97M | 230.45M | 89.19M | 40.90M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
| Interest Income | 0.00 | 142.00K | 243.00K | 231.00K | 378.49K | 1.07M | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 0.00 | 156.00 | 0.00 |
| Interest Expense | -36.97M | 45.73M | 31.20M | 19.13M | 3.25M | 0.00 | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 2.66K | 156.00 | -37.12K |
| Depreciation & Amortization | 27.08M | 26.49M | 8.41M | 4.43M | 2.23M | -15.37K | 7.72K | -3.40M | 15.12K | 17.26K | 14.79K | 18.46K | 11.69K | -156.00 | 0.00 |
| EBITDA | 30.91M | -121.65M | -10.89M | -7.10M | -38.64M | -142.51K | -72.64K | -3.74M | -944.29K | -1.50M | -1.50M | -3.31M | -2.00M | -26.77K | -37.12K |
| EBITDA Ratio | 11.47% | -12.15% | -5.20% | -8.79% | -239.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.82M | -60.69M | -20.36M | -8.42M | -30.67M | -127.15K | -80.36K | -337.76K | -952.32K | -1.50M | -1.58M | -3.40M | -2.01M | -26.62K | -37.12K |
| Operating Income Ratio | -1.05% | -21.35% | -9.73% | -10.43% | -299.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -31.09M | -113.34M | 88.22M | -185.34M | 7.89M | 15.37K | 7.72K | -3.40M | 19.60K | 28.83K | 48.10K | 92.24K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -33.91M | -193.88M | 52.45M | -201.47M | -26.26M | -111.78K | -72.64K | -3.74M | -932.72K | -1.47M | -1.53M | -3.31M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -12.58% | -68.20% | 25.06% | -249.42% | -256.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 32.39M | 8.45M | 31.09M | 10.40M | 4.51M | -15.37K | -7.72K | 3.40M | -39.20K | -75.87K | -33.58K | -115.26K | -5.31K | -312.00 | 37.12K |
| Net Income | -66.30M | -202.32M | 20.25M | -211.87M | -30.77M | -111.78K | -64.92K | -7.14M | -932.72K | -1.47M | -1.53M | -3.31M | -2.01M | -26.62K | -37.12K |
| Net Income Ratio | -24.60% | -71.17% | 9.68% | -262.30% | -300.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.34 | -1.06 | 0.12 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
| EPS Diluted | -0.34 | -0.99 | -0.41 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
| Weighted Avg Shares Out | 194.77M | 190.02M | 170.29M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
| Weighted Avg Shares Out (Dil) | 194.77M | 204.24M | 201.61M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
3 Top Marijuana Stocks To Buy This Quarter
Marijuana stock investors are focused on the future of the cannabis industry. There is a lot in the works that would help keep the sector moving in the right direction. Much of the progress investors want to see is based...
The Sustainability Of Cannabis Bull Run
The DEA is considering reclassifying cannabis from Schedule I to Schedule III, leading to a surge in cannabis stocks. Reclassification could lead to tax breaks, access to banking services, and more efficient logistics for the cannabis industry. Profitable cannabis companies,...
Late September Stock Watchlist: Top Marijuana Stocks to Watch
As we approach the final week of September 2023, the emphasis remains on the expanding US cannabis industry and top marijuana stocks. With an expanding number of states legalizing both medical and recreational marijuana, the industry has become a magnet...
3 Marijuana Stocks To Buy Off The Dips 2023?
Investing in marijuana stocks can be profitable if you can stay disciplined and patient. The discipline part is more about learning and being aware of what is going on in the cannabis sector. So when investing in cannabis stocks you...
Cannabis MSO shares rise with marijuana banking reform poised to win Senate Committee's approval
Cannabis multi-state operator (MSO) stocks are set to end another week on a high on renewed optimism around marijuana banking reform. The Senate Banking Committee is expected to hold a markup session for the Secure and Fair Enforcement (SAFE) Banking...
Top Marijuana Stocks to Watch in Mid September 2023
In the ever-evolving landscape of the United States cannabis industry, mid-September brings excitement as investors set their sights on the top marijuana stocks. With the legal cannabis market gaining ground nationwide, staying informed about the companies poised for growth in...
3 Marijuana Stocks For Better Market Action This Week
Marijuana stock investors are keeping hopes high after a good week of trading. This past week there has been positive news surrounding cannabis reform. There were talks on cannabis banking and how to accomplish this task. As well California also...
Cannabis stock rally continues on marijuana rescheduling hopes
Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.
3 Marijuana Stocks To Buy This Upcoming Week
Marijuana stock investors are keeping their eyes out for any new investment opportunities. For some time there has been more volatility entering the sector. This has been both a positive and negative position for investors. Unfortunately, the downside is a...
Cannabis stocks set to end week on a high following marijuana rescheduling recommendation
Cannabis stocks are on track to finish the week higher boosted by the news that the U.S. Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk drug.
Source: https://incomestatements.info
Category: Stock Reports